InsidersTradesSigma
申报总数
公司
▲ 买入（1 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
1
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Orwin John A, 董事长兼首席执行官. Officer active across 4 companies, notably Travere Therapeutics, Inc.. In total, 18 reports have been logged. Breakdown: 1 buy · 2 sells. Total volume traded: €45k. Activity tracked since 14 May 2021. The latest transaction was filed on 15 September 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Orwin John A
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报18 总计
6,030 股Common StockSEC:0001477384-26-000010:0
1,300 股0Common StockSEC:0001477384-25-000004:0
6,030 股0Common StockSEC:0001415889-25-017589:0
6,500 股0Common StockSEC:0001415889-25-013501:0
1,300 股0Common StockSEC:0001415889-24-023552:0
2,035 股0Common StockSEC:0001415889-24-017508:0
6,500 股0Common StockSEC:0001415889-24-012849:0
1 股@ US$0.010.0% 占其流量Series A Junior Preferred StockSEC:0001415889-24-011059:0
标准退出：2024年7月10日 (T+90)
22,951 股@ US$0.374617.5% 占其流量Class A Common StockSEC:0001415889-24-010243:0
29,003 股@ US$229.00100.0% 占其流量Common StockSEC:0000950170-23-070863:0
2,044 股0Common StockSEC:0001203311-23-000061:0
4,500 股0Common StockSEC:0001209191-23-030956:0
20,908 股@ US$1.775282.5% 占其流量Class A Common StockSEC:0001209191-22-050778:0
1,503 股0Common StockSEC:0000899243-22-018465:0
3,000 股0Common StockSEC:0001209191-22-028699:0
115,400 股0Class A Common StockSEC:0001209191-21-055809:0
3,000 股0Common StockSEC:0001209191-21-033847:0
1,402 股0Common StockSEC:0001203311-21-000032:0
18 条申报中的 18 条
About Orwin John A
Orwin John A is President and Chief Executive Officer. Across 18 filings, the 18 sampled filings cover the period from 2021-05-18 to 2026-06-17 and show €0 of buys and €6,146,276 of sells, mainly through Seagen Inc. and Atreca, Inc.; the recent filings also include transactions categorized as Attribution and other at Anaptysbio, INC.
